The history of Sildenafil presents a intricate picture for shareholders. While the initial release generated substantial profits, the expiration of its patent opened the floodgates to cheaper competitors, dramatically eroding sales. This creates a specific dilemma for drug manufacturers banking on related blockbuster medications, suggesting that a

The legacy of Viagra, and its creator copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in sales , its intellectual property lapse created a wave of lower-priced alternatives , significantly diminishing its dominance. While certain firms may attempt to capitalize on male sexual dysfunction